These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3690885)

  • 1. Vertebral hyperostosis associated with etretinate therapy.
    Papasavvas GK; Bhalla AK; Logan RA
    Clin Exp Dermatol; 1987 May; 12(3):202-3. PubMed ID: 3690885
    [No Abstract]   [Full Text] [Related]  

  • 2. Diffuse hyperostosis associated with etretinate.
    Burge S; Ryan T
    Lancet; 1985 Aug; 2(8451):397-8. PubMed ID: 2862558
    [No Abstract]   [Full Text] [Related]  

  • 3. Extraspinal tendon and ligament calcification associated with long-term therapy with etretinate.
    DiGiovanna JJ; Helfgott RK; Gerber LH; Peck GL
    N Engl J Med; 1986 Nov; 315(19):1177-82. PubMed ID: 3463863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcifying arthropathy of the hips and diffuse hyperostosis associated with etretinate.
    Cerio R; Wells RS; MacDonald DM
    Clin Exp Dermatol; 1987 Mar; 12(2):129-31. PubMed ID: 3677472
    [No Abstract]   [Full Text] [Related]  

  • 5. The safety of etretinate as long-term therapy for psoriasis: results of the etretinate follow-up study.
    Stern RS; Fitzgerald E; Ellis CN; Lowe N; Goldfarb MT; Baughman RD
    J Am Acad Dermatol; 1995 Jul; 33(1):44-52. PubMed ID: 7601945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Skeletal abnormalities caused by etretinate].
    de Groot AC; van der Schroeff JG
    Ned Tijdschr Geneeskd; 1988 Oct; 132(40):1832-3. PubMed ID: 3054577
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vertebral hyperostosis induced by etretinate].
    Hans P; Pompougnac E; Barucq JP; Barucq P; Beylot C
    Rev Rhum Mal Osteoartic; 1988 Dec; 55(12):1027-9. PubMed ID: 3238301
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literature.
    Halverstam CP; Zeichner J; Lebwohl M
    J Cutan Med Surg; 2006; 10(6):291-9. PubMed ID: 17241599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint pains with psoriasis and long-term systemic etretinate therapy: a case report and summary of 12 cases.
    Ishida Y; Ozawa A; Ohkido M; Imai N
    J Dermatol; 1993 Oct; 20(10):651-3. PubMed ID: 8277044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new case of hyperostosis induced by a retinoid].
    Martin A; Lore P; Frocrain L; Chales G; Meadeb J; Lemaître R; Pawlotsky Y
    Rev Rhum Mal Osteoartic; 1989 Oct; 56(10):687-9; discussion 690. PubMed ID: 2688058
    [No Abstract]   [Full Text] [Related]  

  • 11. Minimal spinal hyperostosis with low-dose isotretinoin therapy.
    Kilcoyne RF; Cope R; Cunningham W; Nardella FA; Denman S; Franz TJ; Hanifin J
    Invest Radiol; 1986 Jan; 21(1):41-4. PubMed ID: 2935510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral retinoid therapy for disorders of keratinization: single-centre retrospective 25 years' experience on 23 patients.
    Katugampola RP; Finlay AY
    Br J Dermatol; 2006 Feb; 154(2):267-76. PubMed ID: 16433796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal hyperostosis and extraosseous calcification in patients receiving long-term etretinate (Tigason).
    Wilson DJ; Kay V; Charig M; Hughes DG; Creasy TS
    Br J Dermatol; 1988 Nov; 119(5):597-607. PubMed ID: 3207613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case of the month: " ... or plat du jour".
    Bhattacharya J; Fraser C; MacDonald LM
    Br J Radiol; 1995 May; 68(809):545-6. PubMed ID: 7788246
    [No Abstract]   [Full Text] [Related]  

  • 15. [Skeletal alterations associated with long-term etretinate therapy].
    Okada N; Higashiyama M; Morimoto S; Yoshikawa K
    Nihon Hifuka Gakkai Zasshi; 1991 Apr; 101(5):547-52. PubMed ID: 1890751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombocytopenia associated with etretinate therapy.
    Liang R
    Acta Haematol; 1988; 79(2):112-3. PubMed ID: 3124469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etretinate-induced heterotopic bone formation about the hip joint. A case report including ultrastructural study.
    Inoue K; Imai S; Iwasaki A; Egawa M; Hukuda S
    Clin Orthop Relat Res; 1994 Nov; (308):139-45. PubMed ID: 7955675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral neuropathy during etretinate therapy for psoriasis.
    Hammer CJ; Carter CC; Hanifin JM
    J Am Acad Dermatol; 1993 Feb; 28(2 Pt 1):272-3. PubMed ID: 8381828
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of psoriasis vulgaris whose lipoprotein lipase activity decreased during treatment with etretinate].
    Seishima M; Mori S; Seishima M; Noma A
    Nihon Hifuka Gakkai Zasshi; 1989 May; 99(6):731-4. PubMed ID: 2585775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Successful use of isotretinoin in type Zumbusch generalized pustular psoriasis following recovered etretinate-induced hepatitis].
    Marhold I; Duschet P; Schwarz T; Gschnait F
    Hautarzt; 1991 Sep; 42(9):580-3. PubMed ID: 1938411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.